SpringWorks Therapeutics (SWTX) Insider Trading & Ownership $37.39 -0.20 (-0.53%) As of 02:46 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SpringWorks Therapeutics (NASDAQ:SWTX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage7.61%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$25.24 M Get SWTX Insider Trade Alerts Want to know when executives and insiders are buying or selling SpringWorks Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address SWTX Insider Buying and Selling by Quarter Remove Ads SpringWorks Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/3/2025Badreddin EdrisCOOSell20,000$54.23$1,084,600.00 3/3/2025Saqib IslamCEOSell49,000$54.24$2,657,760.00 2/20/2025Bhavesh AsharInsiderSell1,016$61.19$62,169.04 2/20/2025Daniel LynchDirectorSell47,600$60.22$2,866,472.00 2/20/2025Saqib IslamCEOSell29,328$60.30$1,768,478.40 2/14/2025Daniel LynchDirectorSell400$60.00$24,000.00 2/14/2025Saqib IslamCEOSell10,672$59.92$639,466.24 2/10/2025Badreddin EdrisCOOSell30,000$53.13$1,593,900.00 2/10/2025Daniel LynchDirectorSell175,000$54.46$9,530,500.00 2/10/2025Daniel PichlInsiderSell29,750$54.36$1,617,210.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 2/10/2025Saqib IslamCEOSell48,000$53.30$2,558,400.00 1/29/2025Gilbert Ray Cisneros, Jr.U.S. Congress Member (D-CA)Buy$36.52$1,001 - $15,00012/3/2024Badreddin EdrisCOOSell20,000$41.97$839,400.00 (Data available from 1/1/2013 forward) SWTX Insider Trading Activity - Frequently Asked Questions Who is on SpringWorks Therapeutics's Insider Roster? The list of insiders at SpringWorks Therapeutics includes Badreddin Edris, Bhavesh Ashar, Daniel Lynch, Daniel Pichl, Julie Hambleton, Orbimed Advisors Llc, and Saqib Islam. Learn more on insiders at SWTX. What percentage of SpringWorks Therapeutics stock is owned by insiders? 7.61% of SpringWorks Therapeutics stock is owned by insiders. Learn more on SWTX's insider holdings. Which SpringWorks Therapeutics insiders have been selling company stock? The following insiders have sold SWTX shares in the last 24 months: Badreddin Edris ($3,517,900.00), Bhavesh Ashar ($62,169.04), Daniel Lynch ($12,420,972.00), Daniel Pichl ($2,368,710.00), Julie Hambleton ($135,479.58), and Saqib Islam ($7,624,104.64). How much insider selling is happening at SpringWorks Therapeutics? Insiders have sold a total of 480,584 SpringWorks Therapeutics shares in the last 24 months for a total of $26,129,335.26 sold. Which members of congress are trading SpringWorks Therapeutics? Gilbert Ray Cisneros, Jr. (D-CA) and Josh Gottheimer (D-NJ) have bought shares of SpringWorks Therapeutics in the last year totaling $24,000. Josh Gottheimer (D-NJ) has sold shares totaling $8,000. SpringWorks Therapeutics Key ExecutivesMr. Saqib Islam J.D. (Age 54)CEO & Director Compensation: $1.49MMr. Francis I. Perier Jr. (Age 64)M.B.A., Chief Financial Officer Compensation: $768.24kDr. Badreddin Edris Ph.D. (Age 37)Chief Operating Officer Compensation: $1.02MDr. James Cassidy M.D. (Age 64)Ph.D., Chief Medical Officer Compensation: $904.25kMr. Michael P. Nofi (Age 53)Chief Accounting Officer Mr. Tai-An Lin Ph.D.Chief Scientific OfficerMs. Kim DiamondVice President of Communications & Investor RelationsMr. Herschel S. Weinstein J.D. (Age 67)General Counsel & Secretary Compensation: $568.64kMr. Daniel J. Pichl (Age 40)Chief People Officer Compensation: $428.51k1 recent tradesMr. Bhavesh Ashar M.B.A. (Age 58)Chief Commercial Officer Compensation: $729.62k More Insider Trading Tools from MarketBeat Related Companies MRNA Insider Ownership VTRS Insider Ownership ROIV Insider Ownership LNTH Insider Ownership TGTX Insider Ownership RVMD Insider Ownership BBIO Insider Ownership BPMC Insider Ownership SRPT Insider Ownership AXSM Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Beware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or HoldJoby Aviation: Operational Momentum vs. Market SentimentMicroStrategy Sees Insider Buy-Sell Action in Q1 This page (NASDAQ:SWTX) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredCould this be the start of AI’s Second Wind?We're living in unprecedented times. Most people think it's too late to get into AI right now … That the...Weiss Ratings | SponsoredMarkets in Chaos? Here’s What to Do.Wall Street's on edge with tariffs. And volatility? It's not slowing down. You've seen the headlines… Bu...Investors Alley | SponsoredThis story is about to go viralThis Story Could Go Viral as Soon as May 31 Quietly, towns like Shreveport, Louisiana and Fort Worth, Texas...Stansberry Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SpringWorks Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SpringWorks Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SWTX Stock Free SWTX Stock Alerts